BACKGROUND: Markers of increased health care utilization are surrogates for adverse events, and one such metric--prolonged length of stay greater than 14 days (PLOS)--was recently endorsed as a provider-level performance measure. METHODS: This is a cohort study (1992 through 2002) aimed to describe increased health care utilization among 21,067 operated lung cancer patients using the Surveillance, Epidemiology, and End-Results-Medicare database. Increased utilization was defined by PLOS, discharge to an institutional care facility (ICF), or readmission within 30 days. RESULTS: Twelve percent of patients had a PLOS, 13% were discharged to an ICF, and 15% were readmitted. In multivariate analyses, factors associated with a higher odds ratio of PLOS, discharge to ICF, or readmission included age older than 80 years, increasing comorbidity index, not being married, and pneumonectomy (all p < 0.05). Relative to patients living in the West, those in the Midwest or South had a higher odds ratio of PLOS and readmission but a lower odds ratio of discharge to an ICF (all p < 0.05). Adjusted rates of PLOS decreased significantly with time, whereas adjusted ICF and readmission rates increased (all p < 0.01). Patients who required increased utilization had higher adjusted 2.5-year mortality rates compared with those who did not (PLOS, 42% versus 20%; ICF, 32% versus 20%; readmission, 33% versus 19%; all p < 0.001). CONCLUSIONS: Baseline health status and nonclinical factors were associated with increased utilization, nonuniform trends in utilization were observed with time, and increased utilization was associated with worse long-term outcomes. These findings have implications for quality-improvement initiatives that measure increased health care utilization as a surrogate for provider performance.
BACKGROUND: Markers of increased health care utilization are surrogates for adverse events, and one such metric--prolonged length of stay greater than 14 days (PLOS)--was recently endorsed as a provider-level performance measure. METHODS: This is a cohort study (1992 through 2002) aimed to describe increased health care utilization among 21,067 operated lung cancerpatients using the Surveillance, Epidemiology, and End-Results-Medicare database. Increased utilization was defined by PLOS, discharge to an institutional care facility (ICF), or readmission within 30 days. RESULTS: Twelve percent of patients had a PLOS, 13% were discharged to an ICF, and 15% were readmitted. In multivariate analyses, factors associated with a higher odds ratio of PLOS, discharge to ICF, or readmission included age older than 80 years, increasing comorbidity index, not being married, and pneumonectomy (all p < 0.05). Relative to patients living in the West, those in the Midwest or South had a higher odds ratio of PLOS and readmission but a lower odds ratio of discharge to an ICF (all p < 0.05). Adjusted rates of PLOS decreased significantly with time, whereas adjusted ICF and readmission rates increased (all p < 0.01). Patients who required increased utilization had higher adjusted 2.5-year mortality rates compared with those who did not (PLOS, 42% versus 20%; ICF, 32% versus 20%; readmission, 33% versus 19%; all p < 0.001). CONCLUSIONS: Baseline health status and nonclinical factors were associated with increased utilization, nonuniform trends in utilization were observed with time, and increased utilization was associated with worse long-term outcomes. These findings have implications for quality-improvement initiatives that measure increased health care utilization as a surrogate for provider performance.
Authors: Daniel H Ahn; Nishi Mehta; Jeffrey T Yorio; Yang Xie; Jingsheng Yan; David E Gerber Journal: Clin Lung Cancer Date: 2013-07-22 Impact factor: 4.785
Authors: Sunny Wang; Melisa L Wong; Nathan Hamilton; J Ben Davoren; Thierry M Jahan; Louise C Walter Journal: J Clin Oncol Date: 2012-03-26 Impact factor: 44.544
Authors: Felix G Fernandez; Andrzej S Kosinski; William Burfeind; Bernard Park; Malcolm M DeCamp; Christopher Seder; Blair Marshall; Mitchell J Magee; Cameron D Wright; Benjamin D Kozower Journal: Ann Thorac Surg Date: 2016-05-19 Impact factor: 4.330
Authors: Varun Puri; Aalok P Patel; Traves D Crabtree; Jennifer M Bell; Stephen R Broderick; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Bryan F Meyers Journal: J Thorac Cardiovasc Surg Date: 2015-08-28 Impact factor: 5.209
Authors: Yinin Hu; Timothy L McMurry; James M Isbell; George J Stukenborg; Benjamin D Kozower Journal: J Thorac Cardiovasc Surg Date: 2014-04-18 Impact factor: 5.209
Authors: Robert M Van Haren; Arlene M Correa; Boris Sepesi; David C Rice; Wayne L Hofstetter; Jack A Roth; Stephen G Swisher; Garrett L Walsh; Ara A Vaporciyan; Reza J Mehran; Mara B Antonoff Journal: J Thorac Dis Date: 2020-03 Impact factor: 3.005